Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.
<h4>Background</h4>Hepatitis C virus (HCV) infection is highly prevalent in renal transplant (RT) recipients. Currently, interferon-based (IFN-based) antiviral therapies are the standard approach to control HCV infection. In a post-transplantation setting, however, IFN-based therapies ap...
Guardado en:
Autores principales: | Fang Wei, Junying Liu, Fen Liu, Huaidong Hu, Hong Ren, Peng Hu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f797e27dbda45cfa5f7f70aad8dec00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis.
por: Xiwei Wang, et al.
Publicado: (2014) -
Urolithiasis in Renal Transplantation Patients: An Update of the Literature
por: Abdolreza Mohammadi, et al.
Publicado: (2021) -
Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
por: Aixin Song, et al.
Publicado: (2021) -
Blood Glucose and Renal Function Evaluation in Patients with Viral Hepatitis
por: Hsu WT, et al.
Publicado: (2021) -
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses
por: Qian Chen, et al.
Publicado: (2021)